期刊文献+

系统性硬化症患者静息肺功能的变化 被引量:1

Observation of Static Lung Functions in Systemic Sclerosis
下载PDF
导出
摘要 目的 :比较分析系统性硬化症 (SSc)患者有、无呼吸道症状等不同状态时静息肺功能的变化 ,以观察其不同阶段肺损害的程度。方法 :选择临床确诊的SSc患者 6 8例 ,测定静息肺功能的变化。结果 :无任何呼吸道症状组胸片异常占2 3 .2 % ,弥散功能障碍高达 91.1% ,限制型通气功能障碍占 42 .3 % ,小气道功能障碍占 5 6 .8%。有呼吸道症状组胸片异常占6 6 .7%。无呼吸道症状组和胸片正常组SSc患者实测值占预计值的百分比中均有 2项均值 (FEF2 5%~ 75% 和DLCSO)异常 ,而有呼吸道症状组和胸片异常组则分别有 5项异常。四组均以DLCO、FEF2 5%~ 75% 和PEF下降的发生率和下降幅度最大。各组FEV1/FVC均在正常范围内。结论 :SSc肺功能改变与呼吸系统症状和胸片异常改变有关 ,且早于呼吸系统症状出现和胸片异常改变前。弥散功能障碍和小气道病变是SSc早期的肺功能改变。 Objective: To observe changes of static lung functions in patients with systemic sclerosis (SSc) under different conditions . Methods: Static lung functions were measured by a spirometer in 68 patients with SSc. Results: In the respiratory symptom free SSc group, 23.2% patients have abnormal chest films; 91.1% have diffusing capacity dysfunction; 42.3% have restrictive ventilation dysfunction; and 56.8% have small airway dysfunction. In the respiratory symptom SSc group, 66.7% have abnormal chest films. Two lung function indexes were abnormal both in the respiratory symptom free group and in the normal chest film group. DL CO , FEF 25%~75% and PEF decreased significantly in all patients. VC, TLC, FRC and DL CO in the normal chest film group were higher than those in the abnormal group, respectively. Conclusion: The changes of lung functions in SSc closely correlated to respiratory symptoms and X ray films. Dysfunction of diffusing capacity and small airway were the earliest changes of lung functions in SSc.
出处 《海军医学杂志》 2001年第3期218-221,共4页 Journal of Navy Medicine
关键词 系统性硬化症 肺间质病变 肺功能 胸片 systemic sclerosis interstitial lung disease lung function chest film
  • 相关文献

参考文献5

  • 1胡炳熊 黄定九 潘慧芬等.类风湿性关节炎和系统性硬化症的肺部表现[J].医师进修杂志,1987,11:14-14.
  • 2Domagala LJ, Woser G, Doboszynska A, et al. Interstitial lung disease in systemic sclerosis: comparison of BALF lymphocyte phenotype and DLCO impairment[J]. Respir Med, 1998, 11:1295-1301.
  • 3茌璐琪,刘又宁,朴哲龙,郝峰英,张青勉.慢性阻塞性肺疾病和结缔组织病患者膜弥散与肺血管床容量的分析[J].中华结核和呼吸杂志,1998,21(6):344-347. 被引量:8
  • 4Spagnolatti L, Zoia MC, Volpini E, et al. Pulmonary function in patients with systemic sclerosis[J]. Monaldi Arch Chest Dis, 1997, 52(1):4-8.
  • 5Kane GC, Verga J, Conant EF, et al. Lung involvement in systemic sclerosis (scleroderma): relation to classification vase on extent of skin involvement or autoantibody status[J]. Respir Med, 1996, 4:223-230.

二级参考文献2

  • 1施守义,风湿病学.下,1995年,1063页
  • 2施守义,风湿病学.下,1995年,1083页

共引文献7

同被引文献7

  • 1Subcommittee for scleroderma criteria of the american rheumatism association diagnosis and therapeutic criteria committee. Pretiminary criteria for classtification of systemic sclerosis[J]. Arthritis Rheum,1980,23(5):581-585.
  • 2Spagnolatti L, Zoia MC, Volpini E, et al. Pulmonary function in patients with systemic sclerosis[J]. Monaldi Arch Chest Dis,1997,52(1):4-8.
  • 3Domagala-Kulawik J,Woser G,Doboszynska A,et al.Interstitial lung disease in systemic sclerosis: comparison of BALF lymphocyte phenotype and DLco impairment[J]. Respir Med,1998,92(11):1295-1301.
  • 4Morelli S,Barbieri C,Sgreecia A,et al.Relationship between cutaneous and pulmonary involvement in systemic sclerosis[J].J Rheumatol,1997,24(1):81-85.
  • 5Crestani B,Aubir M.Sclerodermia and alveolar inflammation[J].Rev Mal Respir,1996,13(1):15-20.
  • 6Bolster MB,Ludwicka A,Sutherland SE,et al.Cytokine concentrations in bronchoalveolar lavage fluid of patients with systemic sclerosis[J]. Arthritis Rheum,1997,40(4):743-751.
  • 7Follansbee WP.The cardiovascular manifestations of systemic sclerosis[J]. Current Problemsin Cardiology,1986,11(5):245-290.

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部